Novo Nordisk says it is gradually phasing out human insulin pens globally
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Reuters1h
Merck signs up to $3.3 bln cancer drug deal with China-based LaNova
study suggests 11:22 AM UTC · Updated ago Healthcare & Pharmaceuticalscategory Novo Nordisk says it is gradually phasing out ...
Hosted on MSN17h
Ozempic Scams Are on the Rise-Experts Reveal How to Spot and Avoid Fake Products
Global online protection authority McAfee recently reported a rise in scams centered on brand names Ozempic ... some scammers ...
Humanitarian Organization Criticizes Eli Lilly, Novo Nordisk And Sanofi Of Having 'Double Standards' For High Insulin Price
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
medtechdive19h
Dean Kamen, insulin pump pioneer, wants to shake up diabetes tech
Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...
Us Weekly on MSN13h
Breaking Beauty: Editor Tries the Nails. Inc Mani Marker
On this week’s episode of Breaking Beauty, assistant editor Grace Riley put Nails Inc’s Mani Marker to the test ...
Weight loss drugs Ozempic and Wegovy may also curb alcohol addiction, study says
A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...